5hi4
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists== | ==Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists== | ||
- | <StructureSection load='5hi4' size='340' side='right' caption='[[5hi4]], [[Resolution|resolution]] 1.80Å' scene=''> | + | <StructureSection load='5hi4' size='340' side='right'caption='[[5hi4]], [[Resolution|resolution]] 1.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5hi4]] is a 7 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5hi4]] is a 7 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HI4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5HI4 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=63P:(9S,17R)-6-chloro-N-methyl-9-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-10,19-dioxo-2-oxa-11,18-diazaspiro[cyclopentane-1,21-tetracyclo[20.2.2.2~12,15~.1~3,7~]nonacosane]-1(24),3(29),4,6,12,14,22,25,27-nonaene-17-carboxamide'>63P</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=63P:(9S,17R)-6-chloro-N-methyl-9-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-10,19-dioxo-2-oxa-11,18-diazaspiro[cyclopentane-1,21-tetracyclo[20.2.2.2~12,15~.1~3,7~]nonacosane]-1(24),3(29),4,6,12,14,22,25,27-nonaene-17-carboxamide'>63P</scene>, <scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5hi4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hi4 OCA], [https://pdbe.org/5hi4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5hi4 RCSB], [https://www.ebi.ac.uk/pdbsum/5hi4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5hi4 ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/IL17_HUMAN IL17_HUMAN] Induces stromal cells to produce proinflammatory and hematopoietic cytokines. Enhances the surface expression of ICAM1/intracellular adhesion molecule 1 in fibroblasts. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 21: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5hi4" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5hi4" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Interleukin 3D structures|Interleukin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Synthetic construct]] |
- | [[Category: | + | [[Category: Liu S]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists
|